Antimicrobial Stewardship Program (ASP) measures drive safer and more effective therapies by reducing microbial resistance and costs.
However, few studies show financial advantages.
The attached review, evaluating ASP work in hospitals on five continents, showed a reduction of up to US$ 732.00/patient in the United States and Europe, and that results are lacking in low- and middle-income countries in need of urgent attention
Font:
